Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
LAB
VNDA
Add up to 3 more stocks
LAB
Standard BioTools Inc.
-5.37%
$0.72-0.04Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$282.64M
52W Range
$0.63 - $1.72
VNDA
Vanda Pharmaceuticals Inc.
-1.31%
$4.52-0.06Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$271.81M
52W Range
$4.27 - $9.94
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.52 | 1.23 |
| P/S Ratio | 3.34 | 1.26 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 49.1% | 92.8% |
| Operating Margin | -109.3% | -70.0% |
| Net Margin | -103.3% | -127.4% |
| ROE | -16.2% | -124.8% |
| ROA | -13.9% | -66.6% |
| ROIC | -14.1% | -74.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.10 | 1.61 |
| Quick Ratio | 8.80 | 1.60 |
| Debt/Equity | 0.05 | 0.10 |
| Interest Coverage | -3588.65 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.